MOUNT CAPITAL LIMITED
Company number 04624954 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: MOUNT CAPITAL LIMITED (Company No. 04624954)
1. Financial Health Score: A-
Grade explanation:
The company receives an A- because its core vital signs are strong: positive and growing net assets, robust cash reserves, an unqualified audit opinion, and no overdue statutory filings. The grade is not an A+ because earnings are exposed to investment fair-value swings and revenue is concentrated among a small number of large clients, which introduces a moderate degree of volatility.
2. Key Vital Signs
| Vital Sign | Latest Reading (2022) | Prior Reading (2021)* | Interpretation |
|---|---|---|---|
| Net assets (solvency) | £10.43 million | £9.85 million | Equity is positive and increased by roughly 6%. The company is solvent, with a cushion comparable to healthy blood pressure. |
| Cash at bank (liquidity) | £5.19 million | £2.88 million | Cash rose sharply and equals about 29% of total assets. This is a strong liquidity position, able to cover near-term obligations comfortably. |
| Turnover | £7.09 million | £7.31 million (15 months) | The prior period covered 15 months, so annualised revenue is broadly stable or slightly higher. No sign of a revenue collapse. |
| Operating margin | 29.4% | 17.0% | Margin improved significantly before fair-value and foreign-exchange movements, indicating better operational efficiency. |
| Profit after tax | £1.33 million | £3.73 million | Profit fell mainly because of a £0.96 million fair-value loss on current asset investments. This is a market-driven symptom, not an operational failure. |
| Regulatory capital | Total resources £10.51 million | — | As an FCA-regulated limited licence firm, total capital resources far exceed the base requirement (€125,000) and other Pillar 1 measures. |
| Statutory filings | No overdue accounts or confirmation statements | — | Filings are current; no administrative distress signals. |
*The 2021 comparative covers a 15-month period, so direct comparisons should be treated with caution.
3. Symptoms Analysis
The accounts state that the directors consider the results and financial position satisfactory, and the independent auditor confirms that the going-concern basis is appropriate with no material uncertainties identified.
Positive indicators (healthy symptoms): - Cash reserves more than doubled year on year. - Net assets grew, reinforcing the balance sheet. - Operating margin widened from 17.0% to 29.4%. - No overdue filings or winding-up petitions are evident.
Watch items (symptoms to monitor): - Concentration risk: The strategic report notes that business risk arises mainly from the potential loss of one or more large customers (investment funds) or a reduction in assets under management. Revenue depends on a small number of relationships. - Market and fair-value volatility: A £0.96 million fair-value loss on current asset investments drove the decline in reported profit. This reflects underlying fund performance rather than company operations. - Foreign exchange exposure: Revenues are received largely in US dollars and euros while expenses are mainly in sterling. The company manages this through currency conversion and forwards, but it remains a sensitivity.
4. Diagnosis
Overall condition: Financially stable, solvent, and liquid.
Chronic exposure: Market-linked earnings volatility and client concentration.
Acute risks: None currently identified. The company is not showing symptoms of distress such as negative net assets, cash insolvency, or filing delinquency.
The balance sheet resembles a patient with strong vital signs: ample liquidity, a healthy equity cushion, and a regulatory capital surplus. The main “condition” to manage is sensitivity to investment performance and the loss of a major client, both of which could affect turnover and profit.
5. Prognosis
The outlook is stable to positive, provided that: - investment fund performance and client relationships are maintained, - foreign exchange exposures continue to be hedged appropriately, - cash reserves are preserved to meet working capital and regulatory capital requirements.
Audited accounts confirm the company is a going concern, and regulatory capital resources are well above minimum requirements. The prognosis would deteriorate only if a major client were lost, markets remained weak for an extended period, or cash reserves were eroded by dividends or operating losses without replenishment.
6. Recommendations
- Diversify the client base: Reduce dependence on a small number of large fund customers by pursuing new mandates or fund relationships.
- Maintain the foreign-exchange hedging programme: Continue converting foreign currency receipts and using forwards where appropriate to protect sterling margins.
- Preserve cash reserves: Keep the £5.2 million liquidity buffer available for working capital, regulatory capital needs, and an orderly wind-up scenario if required.
- Conduct regular stress testing: Model the impact of losing a major client or a prolonged investment downturn on revenue, profit, and regulatory capital.
- Keep statutory filings current: Accounts and confirmation statements are already up to date; maintain this compliance to avoid penalties and administrative action.